|
14:30
17:30
|
EN
-
-
-
姚克 Yao KeChina
Speaker
Adances in FLACS Cataract surgery in China has experienced a profound transformation, evolving from traditional practices
to the implementation of advanced techniques like Femtosecond Laser-Assisted Cataract Surgery
(FLACS). This lecture provides an overview of the recent clinical research in Mainland China, focusing on
optimizing surgical workflows, refining patient selection criteria, and evaluating visual and refractive
outcomes associated with FLACS. Data from these studies have contributed to evidence-based protocols
that support the safe and effective implementation of laser-assisted cataract procedures across diverse
clinical settings.
-
Matteo PiovellaItaly
Speaker
Refractive cataract surgery to correct and eliminate presbyopia to achieve better vision in patients undergoing cataract surgerySynopsis Refractive cataract surgery is now replacing standard high-volume, low-cost cataract
surgery with monofocal IOL implantation. The possibility is to correct refractive defects, myopia,
hyperopia and astigmatism and overcome presbyopia limitations. It is necessary to change the
preoperative patient procedures and manage Meibomian gland dysfunction in cataract patients.
Normally three treatments should be applied: BlephEx (Alcon) to eliminate Demodex blepharitis
Biofilm and to open glands duct LipiFlow (J&J) to get postoperative refractive emmetropia. In this
course, we will review state-of-the-art knowledge on refractive cataract surgery in pursuing highly
satisfactory uncorrected distance, intermediate and near vision. Routine dry eye management will
be discussed. Advanced biometry, multiple shots and new procedures will be explained and
demonstrated .The new technical model for the adoption of refractive cataract surgery: biometry evaporative dry eye pupil-dependent trifocal IOLsSynopsis PRESENTATION will certify as postoperative precise IOL power detection is based on quality of
tear film to provide cornea smooth surface.Improvements . Multiple biometry exams are needed
until refractive IOLs power stabilization
Objective The MAPRY/clear oil protocol is based on consecutive session with three phisical
treatments. First treatment applied is Blephex(LLC) to remove Demodex, Biofilm and to unclog
excretory channels of the meibomian glands Second Treatment,LipiFlow (J&J),replaces occlusions
of the MG warming the material responsible of MGD improving a solid sttatification into the liquid
state easier to remove. ILux (Alcon)expels deeply from the meibomian glands the substances
responsible for their obstruction. The MAPRY protocol is based on one session per month at least
for 5 months, depending the grade and penetration ofhronic eyelids inflammation
-
Chan Yun KIMKorea (Republic of)
Speaker
Minimally Invasive Bleb Surgery (MIBS): Redefining Safety and Efficacy in Glaucoma SurgeryMinimally Invasive Bleb Surgery (MIBS) represents a significant advancement in glaucoma treatment, combining the efficacy of traditional filtering procedures with the safety and simplicity of minimally invasive techniques. Devices such as the XEN Gel Stent, PreserFlo MicroShunt, and A-stream enable subconjunctival outflow with less tissue disruption.
This talk will review the core principles of MIBS, compare it with conventional surgery and MIGS, and highlight recent clinical outcomes. MIBS offers a promising surgical option for patients requiring effective intraocular pressure control with a lower risk profile.Advances in Contemporary Glaucoma Surgery: Innovations and Clinical ImpactThe field of glaucoma surgery has undergone remarkable transformation in recent years, driven by innovations aimed at improving efficacy, safety, and patient outcomes. This presentation will explore key advancements in surgical techniques, including the evolution of MIGS (Minimally Invasive Glaucoma Surgery), the emergence of MIBS (Minimally Invasive Bleb Surgery), and improvements in conventional filtering procedures.
Emphasis will be placed on how these innovations have influenced clinical decision-making, expanded surgical options across disease severity, and reshaped postoperative management. By examining current evidence and real-world outcomes, this talk aims to provide a comprehensive overview of the modern surgical landscape in glaucoma care and its practical implications for clinicians.
-
孫興懷 Xinghuai SunChina
Speaker
Sustained drug-release glaucoma systems will replace eye drops"Glaucoma is a lifelong chronic disease, the only proven effective way to control glaucoma is lowering IOP, that’s an important pathological factor. In clinical, surgeries have effective, but not perfect. Eye drops still the keystone of anti-glaucoma treatment. But there are some limitations of anti-glaucoma drops with poor therapeutic benefits, like low aqueous humor bioavailability less 5%, lack of patient compliance, long-term IOP fluctuations with glaucoma progression, and with cumulative drug toxicity or adverse effects caused by drops active pharmaceutical ingredients and additives. So there are need improving therapeutic benefits following the ways like new dosage form/formulation, less relying on patient effort, sustained drug delivery all time and drug delivery with low dose. Sustained release glaucoma systems do much better than eye drops in delivering medications, so the greater therapeutic benefits and the better patient compliance could obtained. There are more and more clinical trials about sustained release systems for glaucoma. We introduced our some research results about lowering IOP sustained systems.
Sustained release system is a general development trend for glaucoma therapy, but most influenced by other two leading factors: out-of-pocket cost and interval between administrations. I think sustained release glaucoma systems will replace eye drops in the future."
Clinical Evaluation of Retinal Blood Flow in Glaucoma by OCTAFollowing the morphological structure of OCT, OCTA has contribute to the in-depth study of the mechanism of nerve damage and treatment evaluation in glaucoma. We have carried out clinical study of OCTA in glaucoma to quantify the peripapillary and parafoveal blood flow index and vessel density. The studies as the following aspects: At first, the POAG with early, middle, and late stages. These indices of blood flow index and vessel density in each stage of POAG gradually decreased. Results showed well diagnostic efficacy of blood flow index and vessel density for POAG. Then, we studied the eyes with acute attacks of PACG after one month when IOP controlled. Results showed the density of peripapillary vessels in PACG decreased significantly during the stages of chronic(PACG), attack(APAC), intermmitent(PAC) compared to preclinical (PACS) and normal controls. The vessel density in the macular area during chronic(PACG) stage is lower than that of normal controls. And we performed OCTA in the eyes before and 1 hour after LPI in 100 cases of PACS. Results indicated transient large IOP fluctuations have a greater impact on retinal blood flow. So, we think the glaucoma need a comprehensive treatment, in addition to lowering IOP, microcirculation should be improved, especially those with pre-existing retinal vascular disease.
-
Pannet PangputhipongThailand
Speaker
Phacoemulsification: Challenging and Interesting CasesPhacoemulsification in complex cases is always challenging. Situations such as hard nucleus, intumescent cataract, posterior polar cataract, loose zonule, or small pupil require special surgical techniques to overcome the difficulties. In some patients, multiple complexities may occur simultaneously, making the procedure extremely challenging—sometimes described as a surgeon’s nightmare.
This presentation will highlight selected interesting cases and demonstrate strategies to manage them safely, guiding surgeons on how to navigate through these “war zone” scenarios with confidence.Challenges in Soft Nucleus: Don’t Drown in Shallow WaterPhacoemulsification in soft nuclei can be challenging if inappropriate techniques are used. The soft nature of the nucleus makes nuclear disassembly difficult. Chopping and rotation are not easily performed because the chopper tends to cut through the nuclear mass when cracking or rotational force is applied, without achieving satisfactory results. The phaco tip also cannot hold the nucleus firmly enough during chopping or pulling.
“Stab Test” using a 27g. hydrodissection canular to determine the hardness of the nucleus before performing hydrodissection is essential, in order to choose the most appropriate phaco technique.
Special techniques such as Hydro Subluxation + Aspiration, Hydro Subluxation + Flip & Chop, Half Bowl + Rim Aspiration, and Chip & Flip (I. Howard Fine) will be discussed, including phacodynamics for soft nuclei.
When proper techniques are applied, surgery can be performed safely and effectively.
-
-
-
-
-
Vicente OcampoPhilippines
Speaker
Ocular TB: The Philippine Experience This talk aims to discuss the fine points in bringing people together to work towards achieving a common goal. It will identify the roles of an effective leader and will differentiate transactional from transformational leadership. It will also tackle the essential elements to a successful endeavor namely - Vision, Resolve, Strategy and People.
-
Muiz MAHYUDINMalaysia
Speaker
Presbyopic Correction with LVC This lecture will explore the viability of laser vision correction (LVC) for presbyopia, focusing on the concepts of presby-LASIK, multifocal ablations, and blended vision strategies. We will discuss the optical compromises inherent in these approaches, such as reduced contrast sensitivity and the occurrence of halos, before reviewing current evidence on outcomes, patient satisfaction, and reported side effects. Clinical cases will be highlighted to illustrate practical applications and challenges in patient selection and counseling. Finally, we will evaluate the balance between the future potential of these techniques and their current limitations, enabling participants to describe the key surgical methods and critically appraise the available evidence regarding efficacy and safety.
-
701B
|
